ArticleVeterinary research2026
Lack of significant impact of deoxynivalenol (DON) on both swine dendritic cell activities and systemic infection caused by a virulent Streptococcus suis serotype 2 strain.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Deoxynivalenol (DON) is a common mycotoxin in swine feed known for its immunomodulatory effects and potential to exacerbate infectious diseases. However, its impact on systemic bacterial infections remains unclear. This study investigated whether DON influences the interaction between porcine marrow-derived dendritic cells (DCs) and Streptococcus suis, a major swine and zoonotic pathogen, as well as the progression of systemic infection in weaned piglets. In vitro exposure of DCs to non-toxic concentrations of DON (0.5 and 1 µM) neither altered the phagocytic uptake or intracellular survival of S. suis, nor did it affect anti-inflammatory cytokine expression. However, a moderate downregulation of IL-6 and IL-8 mRNA expression was observed. In vivo, piglets fed diets naturally contaminated with DON (1 or 2 mg/kg) and challenged with S. suis serotype 2 showed no significant differences in clinical signs, survival rates, or weight gain compared to controls. Although transiently increased bacteremia was observed at early stages post-infection in DON-exposed groups, it did not translate into more severe disease. These results suggest that under the conditions tested, DON has limited impact on DC functionality and does not significantly enhance susceptibility to systemic S. suis infection. This work provides relevant data for swine health risk assessments related to feed contamination with DON.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.